Implantable medical devices with anti-microbial and biodegradable matrices

• US 8,192,481 B2
• Filed: 08/27/2010
• Issued: 06/05/2012
• Est. Priority Date: 06/22/2004
• Status: Expired due to Fees

• Current Assignee: Lifeshield Sciences LLC (Acacia Research Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: King, Tamarah L.
• Primary Examiner(s): Stewart, Alvin J
• Application Number:
  US12/869,870
• Publication Number:
  US 20100324667A1
• Time in Patent Office: 648 Days
• Field of Search: 623 138- 154, 623/1.13, 623/1.23, 623/23.72, 623/23.73, 623/23.74, 623/23.75, 623/23.76
• US Class Current: 623/1.13
• CPC Class Codes: A61F 2/06 Blood vessels
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2002/072 Encapsulated stents, e.g. wire or whole stent embedded in lining
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body

Abstract

A composite vascular graft is provided, which incorporates bioactive agents that can be controllably delivered to the implantation site to deliver therapeutic materials and/or to reduce infection of the implant. The vascular graft of the present invention includes a luminal layer of ePTFE; and a biodegradable polymer layer including a bioactive agent, such as an antimicrobial agent. The biodegradable polymer layer is posited on the external surface of the luminal ePTFE layer. The graft also includes a fabric layer, which is posited on the external surface of the biodegradable layer. The graft is particularly useful as an arterial-venous graft for hemodialysis procedures.

Claims

1. A vascular graft comprising:

a luminal layer of ePTFE, the luminal layer is at least partially sintered;

a biodegradable polymer layer comprising a bioactive agent and at least one biodegradable polymer, the at least one biodegradable polymer comprising a hydrophilic region, at least two functional groups that will allow for cross-linking of the polymer, and a bioresorbable hydrophobic region, the bioactive agent controllably releases from the biodegradable polymer layer to the site of implantation of the graft, the biodegradable polymer layer being posited on the external surface of the luminal layer; and

a fabric layer posited on the external surface of said biodegradable polymer layer;

wherein said at least partially sintered luminal layer and said heat-set fabric layer are bonded together via cross-linking of said biodegradable polymer layer.

2. The vascular graft of claim 1 wherein the bioactive agent is distributed throughout the biodegradable layer.

3. The vascular graft of claim 1 further comprising an implantable prosthetic stent interposed between the luminal layer and the biodegradable polymer layer.

4. The vascular graft of claim 1 wherein the fabric layer comprises a textile construction selected from the group consisting of weaves, knits, braids, filament windings, spun fibers and combinations thereof.

5. The vascular graft of claim 1 wherein said fabric layer comprises a knitted textile construction.

6. The vascular graft of claim 1 wherein said fabric comprises a heat-set diameter.

7. The vascular graft of claim 1 wherein said fabric has a porosity from about 5,000 to about 17,000 on the Wesolowski scale.

8. The vascular graft of claim 1 wherein said bioactive agent is controllably released from said biodegradable layer to the site of implantation of said graft by hydrolysis of chemical bonds in said biodegradable polymer.

9. The vascular graft of claim 1 wherein the biodegradable polymer comprises chemical functional groups, the chemical functional groups comprise at least one member selected from the group consisting of ethers, esters, anhydrides, orthoesters and amides.

10. The vascular graft of claim 1 wherein said polymer is selected from the group consisting of fibrin, collagen, elastin, celluloses, gelatin, vitronectin, fibronectin, laminin, reconstituted basement membrane matrices, starches, dextrans, alginates, hyaluronic acid, poly(lactic acid), poly(glycolic acid), polypeptides, glycosaminoglycans, their derivatives, and mixtures thereof.

11. The vascular graft of claim 1 wherein said polymer is selected from the group consisting of polydioxanones, polyoxalates, poly(alpha-esters), polyanhydrides, polyacetates, polycaprolactones, poly(orthoesters), polyamino acids, polyamides and copolymers thereof, and mixtures thereof.

12. The vascular graft of claim 1 wherein said polymer comprises a member selected from the group consisting of stereopolymers of L- and D-lactic acid, copolymers of bis(p-carboxyphenoxy) propane acid and sebacic acid, sebacic acid copolymers, copolymers of caprolactone, poly(lactic acid)/poly(glycolic acid)/polyethyleneglycol copolymers, copolymers of polyurethane and (poly(lactic acid), copolymers of polyurethane and poly(lactic acid), copolymers of .alpha.-amino acids, copolymers of .alpha.-amino acids and caproic acid, copolymers of .alpha.-benzyl glutamate and polyethylene glycol, copolymers of succinate and poly(glycols), polyphosphazene, polyhydroxy-alkanoates and mixtures thereof.

13. The vascular graft of claim 1 wherein the bioactive agent is an antimicrobial agent that is an antiseptic agent.

14. The vascular graft of claim 1 wherein said bioactive agent is a silver agent.

15. The vascular graft of claim 14 wherein said silver agent comprises silver metal ions.

16. The vascular graft of claim 1 wherein said biodegradable layer comprises a hydrogel.

17. The vascular graft of claim 16 wherein said silver agent comprises silver metal ion, said silver metal ions are present in amounts of about 0.5% to about 2 wt. % of the hydrogel in the biodegradable layer.

18. The vascular graft of claim 1 wherein the antimicrobial agent is an antiseptic agent selected from the group consisting of chlorohexidine, triclosan, iodine, benzalkonium chloride, and combinations thereof.

19. The vascular graft of claim 1, wherein said fabric layer is formed from synthetic yarns selected from the group consisting of polyesters, PET polyesters, polypropylenes, polyethylenes, polyurethanes, polytetrafluoroethylenes and combinations thereof.

20. The vascular graft of claim 1 wherein the fabric layer is formed of synthetic polyester yarns.